Job Description / Duties

CReATe Fertility Center located in downtown Toronto has an immediate opening for a full-time Andrology Technician at the clinical Andrology laboratory to perform daily andrology tests and procedures, as well as to assist in a variety of research activities. We are looking for a motivated, detail-oriented, highly organized BSc or MSc graduate. Laboratory experience in andrology techniques is required. Must be proficient in working with computers, MS Office, MS Access databases and other software aiding laboratory organization. Must be able to work weekends. Candidates should have excellent communication skills, be proficient in English and be immediately eligible for employment in Canada. We thank all applicants for their interest. Please note that only candidates who meet these requirements will be contacted.

Qualifications / Required Skills

BSc or MSc graduate with experience working in a clinical laboratory
Knowledge of reproductive physiology/cell biology
Laboratory experience in andrology techniques and flow cytometry
Prior experience in patient recruitment for research
Must be flexible with work hours and weekend rotation
Candidates should have excellent communication skills in English and be immediately eligible for employment in Canada.

Additional Information

Participation in research initiatives is expected. Prepare abstracts and/or posters as needed.

Salary: Salary is commensurate with experience.

Contact Information

Interested candidates are encouraged send a cover letter and CV to the attention of the Andrology Director, Dr. Sergey Moskovtsev, at sergey@createivf.com

Employer Profile

CReATe Fertility Centre is a Toronto-based health care company with over 20 years of experience in providing advanced reproductive care, including extensive R&D and education programs in the areas of reproductive biology and regenerative medicine. CReATe currently employs over 160 people in Toronto, Ontario, and is conducting research for the advancement of assisted reproductive technologies and the development of new tests for male and female infertility, as well as the development of human umbilical cord stem cell-based therapies.